Rifabutin 150mg Capsules
Overview
What is this medicine?
How to Use This Medicine
To take this medication correctly, follow your doctor's instructions and read all the information provided. You can take this medication with or without food. If it causes stomach upset, taking it with food may help. You have the option to swallow the capsule whole or mix its contents with a soft food like applesauce. If you choose to mix it, consume the mixture immediately and do not save it for later use. Continue taking this medication as directed by your doctor or healthcare provider, even if you start feeling well.
Storing and Disposing of Your Medication
Store this medication at room temperature in a dry location, avoiding the bathroom. Keep all medications in a secure place, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about the best disposal method, consult your pharmacist. You may also want to check if there are drug take-back programs available in your area.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Avoid taking two doses at the same time or taking extra doses.
Lifestyle & Tips
- Take rifabutin exactly as prescribed by your doctor. Do not skip doses or stop taking it early, even if you feel better, as this can lead to drug resistance.
- You can take rifabutin with or without food. If it causes stomach upset, try taking it with food.
- Rifabutin may cause your urine, feces, saliva, tears, sweat, and contact lenses to turn a reddish-orange color. This is harmless but can permanently stain soft contact lenses.
- If you wear soft contact lenses, you may want to switch to glasses during treatment.
- If you are taking hormonal birth control (pills, patch, ring, injection), rifabutin can make it less effective. Use an additional non-hormonal method of birth control (like condoms) while taking rifabutin and for at least one month after stopping it.
- Avoid alcohol or limit intake as it may increase the risk of liver side effects.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Chest pain or pressure
Flu-like symptoms, including:
+ Headache
+ Weakness
+ Fever
+ Chills
+ Aches and pains
+ Sweating
Feeling extremely tired or weak
Shortness of breath
Changes in eyesight, eye pain, or severe eye irritation
Dizziness or fainting
Severe stomach upset or vomiting
Coughing
Abnormal heartbeat
Swollen glands
Diarrhea (especially if it's severe, bloody, or watery) - although diarrhea is common with antibiotics, a rare but serious condition called C. diff-associated diarrhea (CDAD) can occur, which may lead to life-threatening bowel problems
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Signs of severe skin reactions include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
Low white blood cell counts, which can increase the risk of infection - seek medical help if you experience:
+ Fever
+ Chills
+ Sore throat
Low platelet counts, which can increase the risk of bleeding - seek medical help if you notice:
+ Unexplained bruising
+ Unexplained bleeding
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or don't go away, contact your doctor:
Diarrhea
* Upset stomach
Reporting Side Effects
If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Eye pain, redness, or blurred vision (report immediately, as this could be a serious eye condition called uveitis)
- Severe skin rash, blistering, or peeling
- Fever, chills, sore throat, unusual tiredness, or easy bruising/bleeding (signs of blood problems)
- Yellowing of the skin or eyes (jaundice), dark urine, severe stomach pain (signs of liver problems)
- Severe diarrhea, especially if it contains blood or mucus
- Joint pain or swelling
Before Using This Medicine
Any allergies you have, including allergies to this drug, any of its components, or other substances, such as foods or medications. Be sure to describe the symptoms you experienced as a result of the allergy.
If you have been diagnosed with tuberculosis (TB).
If you are currently taking voriconazole.
If you are taking any medications to treat HIV, as some HIV treatments are not compatible with this drug.
It is crucial to note that this is not an exhaustive list of all potential interactions between this medication and other substances. Therefore, it is vital to disclose all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you may have, to your doctor and pharmacist. This will enable them to verify that it is safe for you to take this medication in conjunction with your other treatments. Never initiate, discontinue, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Please note that this medication may cause discoloration of contact lenses. Additionally, it can change the color of your urine, stools, saliva, sweat, tears, and skin to a brown-orange hue. This is a normal and harmless side effect.
If you are using birth control pills or other hormone-based birth control methods, you should be aware that this medication may reduce their effectiveness in preventing pregnancy. To minimize the risk of unplanned pregnancy, consider using an additional form of birth control, such as a condom, while taking this drug.
If you are pregnant, planning to become pregnant, or breastfeeding, it is crucial to consult with your doctor. You will need to discuss the potential benefits and risks of this medication to both you and your baby to make an informed decision.
Overdose Information
Overdose Symptoms:
- Nausea
- Vomiting
- Abdominal pain
- Headache
- Dizziness
- Leukopenia (low white blood cell count)
- Thrombocytopenia (low platelet count)
- Elevated liver enzymes
What to Do:
In case of suspected overdose, seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222 in the US). Treatment is supportive and symptomatic; there is no specific antidote. Gastric lavage may be considered.
Drug Interactions
Contraindicated Interactions
- Voriconazole (significant decrease in voriconazole levels, loss of efficacy)
Major Interactions
- Protease Inhibitors (e.g., Ritonavir, Saquinavir, Indinavir, Nelfinavir - significant dose adjustments required for both agents, increased risk of adverse effects like uveitis with some combinations)
- Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (e.g., Efavirenz, Nevirapine - potential for decreased NNRTI levels)
- Oral Contraceptives (decreased efficacy of hormonal contraceptives, use alternative birth control)
- Clarithromycin (increased rifabutin levels, significantly increased risk of uveitis; consider rifabutin dose reduction)
- Warfarin (decreased anticoagulant effect)
- Cyclosporine, Tacrolimus, Sirolimus (decreased immunosuppressant levels)
- Corticosteroids (decreased corticosteroid levels)
- Dapsone (decreased dapsone levels)
- Methadone (decreased methadone levels, risk of withdrawal)
- Quinidine (decreased quinidine levels)
- Sildenafil, Tadalafil, Vardenafil (decreased PDE5 inhibitor levels)
- Theophylline (decreased theophylline levels)
- Digoxin (potential for decreased digoxin levels)
- Phenytoin, Carbamazepine, Phenobarbital (potential for altered anticonvulsant levels)
Moderate Interactions
- Azithromycin (potential for increased rifabutin levels, monitor for uveitis)
- Fluconazole, Itraconazole, Ketoconazole (potential for increased rifabutin levels, monitor for adverse effects)
- Sulfonylureas (potential for decreased hypoglycemic effect)
- Beta-blockers (potential for decreased beta-blocker levels)
- Calcium Channel Blockers (potential for decreased calcium channel blocker levels)
- Statins (potential for decreased statin levels)
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To establish baseline neutrophil count, as neutropenia is a potential adverse effect.
Timing: Prior to initiation of therapy
Rationale: To establish baseline liver function, as hepatic impairment can occur.
Timing: Prior to initiation of therapy
Rationale: To assess baseline renal function, especially if dose adjustment may be considered for severe impairment.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Monthly or as clinically indicated, especially during the first few months of therapy
Target: Maintain neutrophil count >1000 cells/mm³
Action Threshold: If neutrophil count falls below 1000 cells/mm³, consider dose reduction or interruption; if severe neutropenia, discontinue.
Frequency: Periodically or as clinically indicated
Target: Within normal limits or stable
Action Threshold: Significant elevations may warrant dose adjustment or discontinuation.
Frequency: If symptoms of uveitis develop (e.g., eye pain, redness, blurred vision)
Target: Not applicable
Action Threshold: Prompt evaluation and potential discontinuation if uveitis is confirmed.
Symptom Monitoring
- Eye pain, redness, blurred vision (signs of uveitis)
- Skin rash, itching, hives
- Fever, sore throat, unusual tiredness (signs of neutropenia or other infection)
- Unusual bleeding or bruising
- Joint pain or swelling
- Nausea, vomiting, abdominal pain
- Yellowing of skin or eyes (jaundice), dark urine (signs of liver problems)
Special Patient Groups
Pregnancy
Rifabutin is Pregnancy Category C. Animal studies have shown adverse effects on the fetus, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Rifabutin is excreted into human breast milk. Due to the potential for serious adverse reactions in nursing infants (e.g., discoloration of body fluids, theoretical risk of developing drug-resistant organisms), a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Safety and efficacy have not been established in pediatric patients under 18 years of age for MAC prophylaxis. It is used off-label for the treatment of tuberculosis in children as part of multi-drug regimens, with doses adjusted by weight. Close monitoring for adverse effects is crucial.
Geriatric Use
No specific dose adjustment is generally required for elderly patients. However, due to the higher likelihood of decreased renal or hepatic function and polypharmacy in this population, close monitoring for adverse effects and drug interactions is recommended.
Clinical Information
Clinical Pearls
- Rifabutin is a potent inducer of CYP3A4, leading to numerous significant drug interactions, especially with antiretrovirals (PIs, NNRTIs), oral contraceptives, and immunosuppressants. Careful medication reconciliation and dose adjustments are often necessary.
- The most notable adverse effect is uveitis, particularly at higher doses or when co-administered with clarithromycin. Patients should be educated to report any eye pain, redness, or blurred vision immediately.
- Causes reddish-orange discoloration of urine, feces, saliva, tears, sweat, and contact lenses. This is a benign effect but can be alarming to patients.
- Neutropenia is a potential hematologic side effect; regular CBC monitoring is important, especially during the initial months of therapy.
- Often used as an alternative to rifampin in TB regimens when drug interactions with rifampin are problematic (e.g., with certain HIV medications), though rifabutin still has significant interactions.
Alternative Therapies
- For MAC: Azithromycin, Clarithromycin, Ethambutol, Amikacin, Streptomycin
- For TB: Isoniazid, Pyrazinamide, Ethambutol, Moxifloxacin, Levofloxacin, Bedaquiline, Pretomanid, Delamanid